PIN27 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1303
https://www.valueinhealthjournal.com/article/S1098-3015(12)01368-X/fulltext
Title :
PIN27 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01368-X&doi=10.1016/j.jval.2012.03.1303
First page :
A241
Section Title :
Infection
Open access? :
No
Section Order :
831